Keyphrases
Hypertrophic Cardiomyopathy
100%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
100%
Cardiovascular Events
100%
Clinical Risk Models
100%
SVEP1
100%
Major Adverse Cardiovascular Events
70%
Clinical Predictors
30%
Performance Prediction
20%
Cox Proportional Hazards Model
20%
C-statistic
20%
Peptide Model
20%
High Risk
10%
Multicenter Cohort Study
10%
Adjusted Hazard Ratio
10%
Heart Failure Hospitalization
10%
Sushi
10%
Genetic Causes
10%
Epidermal Growth Factor
10%
Extracellular Matrix Protein 1 (ECM1)
10%
Clinical Parameters
10%
Least Absolute Shrinkage and Selection Operator (LASSO)
10%
Inherited Cardiomyopathy
10%
Cardiac Death
10%
Von Willebrand Factor
10%
Pentraxin 3 (PTX3)
10%
Performance-based
10%
10-fold Cross Validation
10%
Median Level
10%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Natriuretic Peptide
100%
Hypertrophic Cardiomyopathy
100%
Cardiovascular Disease
100%
Prospective Cohort Study
14%
Congestive Heart Failure
14%
Cross-Validation
14%
Epidermal Growth Factor
14%
Matrix Protein
14%
Heart Death
14%
Myocardial Disease
14%
Von Willebrand Factor
14%
Pentraxin
14%
Biochemistry, Genetics and Molecular Biology
N-Terminus
100%
Blood Plasma
100%
Brain Natriuretic Peptide
100%
Genetics
12%
Prospective Cohort Study
12%
Epidermal Growth Factor
12%
Extracellular Matrix Protein
12%
Natriuretic Peptide
12%
Von Willebrand Factor
12%
Pentraxin
12%